ESMO AI & Digital Oncology Congress 2026
16 November 2026 – 18 November 2026
The ESMO AI & Digital Oncology Congress 2026, organised by the European Society for Medical Oncology (ESMO), takes place from 16 to 18 November 2026 at CityCube – Messe Berlin in Berlin, Germany, with sessions also available through a virtual platform. The congress brings together healthcare and digital health experts to explore research, ethical dialogue and technological innovation in cancer care, covering advances in AI and digital oncology, methodology, ethics, regulation and clinical implementation, and the path from research into practice.
44 sessions · 86 speakers
Organiser (1)
European Society for Medical Oncology (ESMO)
Sponsors (9)
Flatiron Health · SOPHiA GENETICS · Biorce · Nexomic · HemOnc.org LLC · Boehringer Ingelheim · AstraZeneca · Nucs AI · myTomorrows
Exhibitors (6)
SOPHiA GENETICS · Biorce · Nexomic · AstraZeneca · Nucs AI · myTomorrows
Startups (6)
Gosta Labs · Qnomx AG · Panakeia · TwinEdge Bioscience · Risklick · Kognitic, Inc.
Agenda
- Johnson & Johnson - Precision medicine: Trials meet routine care 16 November 2026 · The Stage
- Translating multimodal AI into cancer diagnostics: a case study of Polaris™ Breast 16 November 2026 · Startup Stage
- Flatiron Health - Predictive modeling's next frontier in oncology drug development 16 November 2026 · The Stage
- AI Agents for Data Cleaning and Medical Review in Oncology trials 16 November 2026 · Startup Stage
- AstraZeneca - Advancing computational pathology for biomarker discovery: From QCS to foundation models and multimodal analysis 16 November 2026 · The Stage
- Welcome to the ESMO AI & Digital Oncology Congress 2026 16 November 2026 · Alpha 1
- Maths and AI to enable new discovery research in cancer 16 November 2026 · Alpha 1
- Edu AI 2026 basics 16 November 2026 · Alpha 1
- The Oncology AI Reliability Gap. Your agent is not the problem. Is your data ready for the question you are asking? 16 November 2026 · Startup Stage
- Biorce - From protocol to first patient: A connected-systems approach to oncology trial design 16 November 2026 · The Stage
- Rapid Oral session 16 November 2026 · Alpha 1
- The AI Operating System for Oncology 16 November 2026 · Startup Stage
- Fraunhofer IIS - Histopathology & spatial biology under one roof: Analyze your slides with MIKAIA 16 November 2026 · The Stage
- Digital health in oncology 16 November 2026 · Alpha 2
- Real-world data 16 November 2026 · Alpha 1
- Multimodal foundation models methodology 17 November 2026 · Alpha 1
- SOPHiA GENETICS - Beyond genomics: Shaping the next era of precision medicine 17 November 2026 · The Stage
- Histotype Px® Colorectal – world’s most advanced and regulatory-approved prognostic AI biomarker using an H&E slide 17 November 2026 · Startup Stage
- AI and clinical trials 17 November 2026 · Alpha 1
- Multimodal foundation models and agents in oncology 17 November 2026 · Alpha 1
- AstraZeneca - AIforHeR a rigorous evaluation of 7 AI solution for HER2 scoring in breast cancer 17 November 2026 · The Stage
- From Fragmentation to Acceleration: Rethinking Oncology Trial Recruitment 17 November 2026 · Startup Stage
- MSD - Connecting digital pathology and precision medicine to improve patient outcomes 17 November 2026 · The Stage
- If you can't trace it, you can't sign it out. From VCF to clinician report with evidence-first AI: every source shown, human approval before every release 17 November 2026 · Startup Stage
- Proffered Paper session 17 November 2026 · Alpha 1
- Digital Patient Avatars: unlocking patient-specific molecular insights at phase-III scale, bringing speed and efficiency to Precision Oncology 17 November 2026 · Startup Stage
- Nucs AI: Detection, prediction, and monitoring for theranostics and molecular imaging 17 November 2026 · The Stage
- Biomarkers and precision oncology 17 November 2026 · Alpha 2
- AI for early detection 17 November 2026 · Alpha 1
- ePoster session 17 November 2026 · Exhibition
- Poster display session & coffee break 17 November 2026 · Exhibition
- myTomorrows - Responsible AI for trial recruitment: A practical framework from pre-screening to enrollment 17 November 2026 · The Stage
- PaiX Navigator: A User-Friendly Agentic Workspace for Harmonized, Multimodal Global Data to Support Equitable Oncology AI 17 November 2026 · Startup Stage
- Frontier of AI methodology 18 November 2026 · Alpha 1
- Boehringer Ingelheim - Advancing t-cell engager delivery: The role of collaboration and fit-for-purpose technology 18 November 2026 · The Stage
- Unlocking biology at scale: AI for precision medicine in drug discovery and clinical decision making 18 November 2026 · Startup Stage
- Autonomous AI 18 November 2026 · Alpha 1
- Johnson & Johnson - AI & Digital Methods: J&J Examples 18 November 2026 · The Stage
- Closing data issues before database lock: AI-assisted, human-governed data review for oncology trials 18 November 2026 · Startup Stage
- Accelerating Oncology Protocol Development from Months to Days 18 November 2026 · Startup Stage
- Nexomic - Beyond biomarkers: Decoding tumour biology with multiomic AI 18 November 2026 · The Stage
- Human-AI interaction in the real-world 18 November 2026 · Alpha 2
- Implementation of AI 18 November 2026 · Alpha 1
- Application of multimodal AI 18 November 2026 · Alpha 1